Oncolys BioPharma Inc.
TSE:4588.T
571 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,287.763 | 1,711.28 | 3,454.714 | 2,067.927 | 3,342.585 | 2,463.138 | 2,867.512 | 2,564.045 | 3,605.286 | 4,727.483 | 5,579.61 | 696.975 |
| Short Term Investments
| 245.081 | 245.079 | 245.078 | 245.077 | 245.07 | 245.064 | 945.058 | 1,145.051 | 1,545.033 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,532.844 | 1,711.28 | 3,454.714 | 2,067.927 | 3,342.585 | 2,463.138 | 2,867.512 | 2,564.045 | 3,605.286 | 4,727.483 | 5,579.61 | 696.975 |
| Net Receivables
| 101.745 | 872.719 | 731.622 | 467.255 | 467.777 | 143.183 | 185.33 | 167.317 | 51.029 | 138.219 | 29.808 | 15.457 |
| Inventory
| 5.342 | 24.249 | 11.656 | 10.472 | 14.917 | 11.062 | 18.58 | 15.118 | 15.711 | 18.781 | 21.613 | 18.051 |
| Other Current Assets
| 315.952 | 0.506 | 0.016 | 0.022 | 1.15 | 0.732 | 0.291 | 0.038 | 1.676 | 0.248 | 0.215 | 0.228 |
| Total Current Assets
| 1,955.883 | 2,608.754 | 4,198.008 | 2,545.676 | 3,826.429 | 2,618.115 | 3,071.713 | 2,746.518 | 3,673.702 | 4,884.731 | 5,631.246 | 730.711 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 20.99 | 21.149 | 21.22 | 42.547 | 39.356 | 30.555 | 31.718 | 29.98 | 77.981 | 95.819 | 49.751 | 58.703 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0.65 | 0.85 | 0 | 0 | 0 | 4.132 | 0.853 | 1.261 | 1.669 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0.65 | 0.85 | 0 | 0 | 0 | 4.132 | 0.853 | 1.261 | 1.669 |
| Long Term Investments
| 63.585 | 21.036 | 55.539 | 143.524 | 430.586 | 780.556 | 421.546 | 362.213 | 280.003 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | -143.524 | -430.586 | 0 | 0 | 0 | -280.003 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.14 | 0.019 | 17.109 | 207.539 | 513.421 | 0.884 | 1.242 | 1.601 | 250.141 | 27.356 | 14.392 | 9.282 |
| Total Non-Current Assets
| 84.715 | 42.204 | 93.868 | 250.736 | 553.627 | 811.995 | 454.506 | 393.794 | 332.254 | 124.028 | 65.404 | 69.654 |
| Total Assets
| 2,040.598 | 2,650.959 | 4,291.876 | 2,796.413 | 4,380.056 | 3,430.112 | 3,526.222 | 3,140.313 | 4,005.959 | 5,008.761 | 5,696.651 | 800.366 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 193.354 | 60.858 | 106.247 | 206.61 | 253.275 | 71.012 | 88.74 | 89.739 | 43.944 | 40.826 | 36.57 | 10.098 |
| Short Term Debt
| 135.341 | 231.357 | 241.554 | 152.152 | 130.923 | 89.131 | 103.158 | 73.151 | 103.795 | 183.044 | 159.727 | 63.66 |
| Tax Payables
| 18.844 | 2.931 | 59.242 | 33.486 | 119.687 | 35.933 | 32.826 | 24.634 | 10.483 | 12.136 | 18.359 | 7.82 |
| Deferred Revenue
| -193.354 | -60.858 | -106.247 | -206.61 | -253.275 | -71.012 | -88.74 | 36.801 | 25.038 | 35.741 | 28.047 | 13.999 |
| Other Current Liabilities
| 243.19 | 90.282 | 188.657 | 263.092 | 392.878 | 123.193 | 135.877 | 5.158 | 4.189 | 3.26 | 8.584 | 2.965 |
| Total Current Liabilities
| 378.531 | 321.639 | 430.211 | 415.244 | 523.801 | 212.324 | 239.035 | 204.849 | 176.966 | 262.871 | 232.928 | 90.722 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 161.1 | 162.302 | 261.916 | 372.923 | 397.299 | 312.449 | 351.58 | 315.297 | 324.96 | 365.751 | 358.522 | 228.218 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.699 | 8.189 | 7.564 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.954 | 3.352 | 1.386 |
| Other Non-Current Liabilities
| 26.869 | 7.749 | 5.757 | 4.92 | 4.909 | 4.185 | 3.712 | 2.784 | 2.562 | 0.001 | 0.001 | 0.001 |
| Total Non-Current Liabilities
| 187.969 | 170.051 | 267.673 | 377.843 | 402.208 | 316.634 | 355.292 | 318.081 | 327.522 | 374.405 | 370.064 | 237.169 |
| Total Liabilities
| 566.5 | 491.69 | 697.884 | 793.087 | 926.009 | 528.958 | 594.327 | 522.93 | 504.488 | 637.276 | 602.992 | 327.891 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 2.799 | 5.477 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 3,623.165 | 3,000 | 9,039.516 | 7,436.537 | 7,121.273 | 6,402.658 | 5,802.444 | 5,090.981 | 5,072.338 | 5,072.278 | 5,059.448 | 2,442.98 |
| Retained Earnings
| -3,373.199 | -1,434.694 | -14,516.735 | -12,901.296 | -10,806.209 | -9,893.863 | -8,660.016 | -7,569.313 | -6,637.915 | -5,780.624 | -5,041.625 | -4,406.071 |
| Accumulated Other Comprehensive Income/Loss
| 14.683 | 7.68 | 7.68 | 7.496 | 15.56 | -2.799 | -5.477 | 12.234 | 10,137.176 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,209.448 | 586.283 | 9,063.531 | 7,460.589 | 7,123.423 | 6,392.359 | 5,789.467 | 5,083.481 | -5,070.128 | 5,079.831 | 5,075.836 | 2,435.566 |
| Total Shareholders Equity
| 1,474.097 | 2,159.269 | 3,593.992 | 2,003.326 | 3,454.047 | 2,901.154 | 2,931.895 | 2,617.383 | 3,501.471 | 4,371.485 | 5,093.659 | 472.475 |
| Total Equity
| 1,474.097 | 2,159.269 | 3,593.992 | 2,003.326 | 3,454.047 | 2,901.154 | 2,931.895 | 2,617.383 | 3,501.471 | 4,371.485 | 5,093.659 | 472.475 |
| Total Liabilities & Shareholders Equity
| 2,040.597 | 2,650.959 | 4,291.876 | 2,796.413 | 4,380.056 | 3,430.112 | 3,526.222 | 3,140.313 | 4,005.959 | 5,008.761 | 5,696.651 | 800.366 |